The global advanced wound care OTC market size is anticipated to reach USD 16.04 billion by 2033 and is expected to expand at a CAGR of 9.73% during the forecast period, according to a new report by Grand View Research, Inc. Market is being driven by a combination of demographic shifts, rising consumer awareness, and technological innovation.One of the central factors contributing to this expansion is the increasing prevalence of chronic wounds, such as diabetic foot ulcers, pressure ulcers, and venous leg ulcers. As the global burden of diabetes and obesity continues to rise, so too does the incidence of these complex wounds, necessitating more accessible and effective treatment options. OTC advanced wound care products offer a convenient solution for patients seeking immediate care without the need for clinical intervention, thereby fueling market demand.
Additionally, the aging population is playing a pivotal role in shaping market dynamics. Older adults are more susceptible to skin breakdown and delayed wound healing, which has led to a surge in demand for specialized wound care products that can be used at home. The availability of OTC solutions—ranging from hydrocolloid dressings to antimicrobial gels—empowers individuals to manage minor and moderate wounds independently, reducing the strain on healthcare systems and improving patient outcomes.
Order a free sample PDF of the Advanced Wound Care OTC Market Intelligence Study, published by Grand View Research.
Further key findings from the report suggest:
1) Based on product, the foam dressings segment led the market with the largest revenue share of 20.33% in 2024.
2) Based on application, the acute wounds segment led the market with the largest revenue share of 75.54% in 2024.
3) By distribution channel, the retail pharmacies / drugstores segment led the market with the largest revenue share of 57.89% in 2024.
4) North America dominated the advanced wound care OTC market with the largest revenue share of 47.03% in 2024.